$CLVT

CLARIVATE PLC

CIK:0001764046|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenues	$ 587.3	$ 621.4	$ 1,172.8	$ 1,215.1
Operating Expenses:
Cost of revenues	185.5	203.6	377.6	410.6
Selling, general and administrative costs	181.6	181.1	357.9	359.5
Depreciation and amortization	185.7	190.9	369.7	376.3
Goodwill and intangible asset impairments	221.7	0.0	221.7	0.0
Restructuring costs	12.1	9.3	24.1	34.0
Other operating expense (income), net	0.9	29.6	(8.2)	48.6
Total operating expenses	787.5	614.5	1,342.8	1,229.0
Income (loss) from operations	(200.2)	6.9	(170.0)	(13.9)
Interest expense, net	60.4	66.6	119.4	130.9
Income (loss) before income taxes	(260.6)	(59.7)	(289.4)	(144.8)
Provision (benefit) for income taxes	8.0	12.3	19.4	31.1
Net income (loss)	$ (268.6)	$ (72.0)	$ (308.8)	$ (175.9)
Per share
Basic (in dollars per share)	$ (0.42)	$ (0.11)	$ (0.48)	$ (0.26)
Diluted (in dollars per share)	$ (0.42)	$ (0.11)	$ (0.48)	$ (0.26)
Weighted average shares used to compute earnings per share:
Basic (in shares)	639.4	681.3	640.0	685.5
Diluted (in shares)	639.4	681.3	640.0	685.5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Flows From Operating Activities
Net income (loss)	$ (308.8)	$ (175.9)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	369.7	376.3
Share-based compensation	29.4	29.3
Goodwill and intangible asset impairments	221.7	0.0
Amortization and write-off of debt issuance costs	6.6	7.7
Other operating activities	(14.0)	48.0
Changes in operating assets and liabilities:
Accounts receivable	(11.3)	2.2
Prepaid expenses	(13.3)	(1.5)
Other assets	(5.0)	3.1
Accounts payable	3.2	(3.3)
Accrued expenses and other current liabilities	(54.3)	(36.1)
Deferred revenues	24.4	42.6
Operating leases, net	(1.9)	(3.2)
Other liabilities	(1.7)	3.7
Net cash provided by operating activities	233.4	287.5
Cash Flows From Investing Activities
Capital expenditures	(110.5)	(126.9)
Net cash used for investing activities	(110.5)	(126.9)
Cash Flows From Financing Activities
Principal payments on debt	(211.1)	(500.0)
Proceeds from Issuance of Debt	0.0	500.0
Payment of debt issuance and extinguishment costs	0.0	(8.5)
Payments for Repurchase of Equity	18.1	99.5
Payments related to tax withholding for share-based compensation	(6.6)	(8.1)
Other financing activities	4.6	5.6
Net cash used for financing activities	(231.2)	(110.5)
Effects of exchange rates	(3.2)	17.3
Net change in cash and cash equivalents, including restricted cash	(111.5)	67.4
Cash and cash equivalents, including restricted cash, beginning of period	329.2	295.2
Cash and cash equivalents, including restricted cash, end of period	217.7	362.6
Deferred income taxes	$ (11.3)	$ (5.4)

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents, including restricted cash	$ 217.7	$ 329.2
Accounts receivable, net	827.9	821.7
Prepaid expenses	107.1	94.2
Other current assets	61.5	64.9
Total current assets	1,214.2	1,310.0
Property and equipment, net	49.5	52.7
Other intangible assets, net	7,734.3	8,008.1
Goodwill	1,344.9	1,566.7
Other non-current assets	86.5	68.1
Deferred income taxes	17.9	17.2
Operating lease right-of-use assets	38.8	46.6
Total assets	10,486.1	11,069.4
Current liabilities:
Accounts payable	152.9	150.6
Accrued compensation	99.0	146.7
Accrued expenses and other current liabilities	268.5	273.0
Current portion of deferred revenues	897.0	878.6
Current portion of operating lease liability	16.7	18.4
Current portion of long-term debt	1.6	101.5
Total current liabilities	1,435.7	1,568.8
Long-term debt	4,209.3	4,321.5
Other non-current liabilities	75.8	86.2
Deferred income taxes	197.9	212.1
Operating lease liabilities	29.9	37.9
Total liabilities	5,948.6	6,226.5
Commitments and contingencies (Note 12)
Shareholders' equity:
Ordinary Shares, no par value; unlimited shares authorized; 639.7 and 640.7 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	12,815.2	12,810.6
Accumulated other comprehensive loss	(454.3)	(453.1)
Accumulated deficit	(7,823.4)	(7,514.6)
Total shareholders' equity	4,537.5	4,842.9
Total liabilities and shareholders' equity	$ 10,486.1	$ 11,069.4
Common Stock, Shares Authorized, Unlimited [Fixed List]	Unlimited	Unlimited